中央研究院院士鄭永齊博士(8化)


鄭永齊博士

鄭永齊博士在抗癌及病毒藥物學的領域裏領導群倫，卓然有成。他曾發表300多篇有關治療癌症及病毒有關疾病的新觀念及新化合物的學術論文。

最近鄭博士更從事中藥治癌的研究。目前他有五種抗癌、B型肝炎病毒及愛滋病毒的化學藥品正在接受臨床實驗。

鄭系友從東海化學系畢業後(1966)，赴美深造，於1972年榮獲布朗大學博士，在耶魯名師手下接受博士後訓練。然後在紐約州水牛城及北卡大學擔任教職，遂後到耶魯大學任教及研究迄今。

鄭博士除了教書及研究外，還擔任許多學術論文期刊之編輯，在美國NIH，國家健康研究機構，台灣、香港等癌症、愛滋研究機構擔任要職，鄭博士工作勤奮，在學術研究、編輯及商業上俱有眾多收獲與貢獻，而且生產力豐富，令人欽佩。

鄭博士與妻Elaine育有兩位子女。現住在美國康州。

BIOGRAPHICAL SKETCH
Dr. Yung-Chi Cheng has been a leader in cancer and viral pharmacology. He has more than 300 publications ranging from the development of new concepts to the discovery of new compounds for the treatment of cancer and viral-associated diseases. Recently Dr. Cheng has developed an interest in the use of Traditional Chinese Medicine for the treatment of cancer. Currently there are five chemicals that were discovered in his laboratory that are under clinical trials for the treatment of cancer, Hepatitis B Virus, and Human Immunodeficiency Virus.
Dr. Cheng received his B.Sc. in Chemistry from Tunghai University of Taiwan in 1966 and his Ph.D. in Biochemical Pharmacology from Brown University under the direction and mentorship of Professor R.E. Parks, Jr. in 1972. His postdoctoral training was obtained in the Department of Pharmacology at Yale University under the direction of Professor William H. Prusoff from 1972 to 1974. In 1974 Dr. Cheng was appointed to the faculty of the Roswell Park Memorial Institute in Buffalo, N.Y., remaining there until 1979 when he was recruited by the University of North Carolina at Chapel Hill as Professor of Pharmacology, Medicine and Director of the Developmental Therapeutics Program of the Cancer Center. He remained at this institution until 1989, at which time he returned to Yale University as the Henry Bronson Professor of Pharmacology, Professor of Medicine and Director of the Developmental Therapeutics Program of the Yale Comprehensive Cancer Center. This latter program consists of more than 30 faculty members from different departments, including Pharmacology, Medicine, Pathology, Genetics, Radiation Therapy, Dermatology, Chemistry and Biology. He is on the Editorial Board of many journals.
His leadership in antiviral and anticancer research has been recognized by his service as a member and Chairman of the Therapeutic Study Section of NIH, a member of the Board of Scientific Counselors of the Division of Cancer Treatment of the National Cancer Institute, and a member of the AIDS Research Advisory Committee of NIH, and a member of the Board of Directors of the American Association for Cancer Research. He was elected as a Special Advisor to the Committee for the Biotechnology Industry under Executive Yuan in Taiwan. He was Chairman of the Action Committee for Medical Biotechnology in Academia Sinica in Taiwan, as well as Chairman of the Biopharmaceutical Division of Scientific Counselors for the National Health Research Institute in Taiwan. He was on a special panel of the Hong Kong government which provides advice on research funding in Biomedical Science. He also serves as a consultant for many pharmaceutical fi rms. He is also scientific founder of two biotechnology companies sponsored by Yale University.
Throughout his career he has received many honors. These include a Leukemia Society of America Scholar Award, the Rhodes Memorial Award from the American Association for Cancer Research, an Outstanding Investigator Award from the National Cancer Institute, an Outstanding Alumni Awards from Tunghai University and Brown University, and Outstanding Investigator Award in Bio-Medical Science from the Society of Chinese Bioscientists in America. He has also received several Honorary Professorships, including an Honorary Professorship from the Union Medical University and the Chinese Academy of Medical Science in China, an Honorary Professorship from Beijing Medical University, a Special Chair of Academia Sinica, Taiwan, an Honorary Professor , Institue of Material Medica, Chinese Academy of Science and the title of Honorary Visiting Scientist of the Institute for the Advancement of Chinese Medicine in Hong Kong. In addition, he has been invited to give the plenary lecture at many professional meetings around the world. He has been elected as an academician of Academia Sinica in 1994 and in 1998 became a member of the Connecticut Academy of Sciences and Engineering. Dr. Cheng is a recipient of the 1999 ASPET (American Society of Pharmacology and Experimental Therapeutics) Award for excellence in his research field.

連絡地址: 407-04 台中市西屯區台灣大道1727號 (Box864)
 TEL：886-4-23590121轉32210  FAX：886-4-23590426